CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in TSHA — Taysha Gene Therapies, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in TSHA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,084,437
-$2,381,942 QoQ
Shares Held
1,808,599
-5.0% QoQ
Ownership
0.629%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TSHA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. TSHA ranks #104 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in TSHA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,084,437 | 1,808,599 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,466,379 | 1,902,978 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,038,087 | 1,846,510 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,135,847 | 491,709 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $760,507 | 547,128 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $820,464 | 474,257 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $930,362 | 462,867 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $962,626 | 429,744 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $147,695 | 51,462 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $28,567 | 16,140 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $51,002 | 16,140 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $10,668 | 16,140 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $12,879 | 16,140 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $36,476 | 16,140 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $31,150 | 16,140 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $337,444 | 90,711 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,078,049 | 165,345 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,893,824 | 162,560 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,949,538 | 158,407 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,845,036 | 87,030 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,182,332 | 58,243 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,386,237 | 52,232 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||